HPV-test, Cervical Cancer and Follow-up

Recurrence After Surgery for Cervical Cancer - an Evaluation of the Follow-up Program.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02096016

Enrollment

Registered

2014-03-26

Start date

2014-01-31

Completion date

2019-12-31

Last updated

2017-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Papilloma Virus, Recurrence, Uterine Cervical Neoplasms

Keywords

Surveillance, Follow up

Brief summary

The investigators have planned this project to evaluate the follow-up program after surgery due to cervical cancer and to explore the possibilities for different tests of Human Papilloma Virus (HPV) in contributing to the customization of the follow-up program. Purpose: The investigators effort is to provide the background for an evidence-based update of the follow-up program after surgery due to cervical cancer with the purpose of early diagnosis of recurrence affecting quality of life for as few women as possible.

Interventions

PROCEDUREHuman Papilloma Virus test from the vaginal vault

Surveillance after surgical treatment of early stage cervical cancer

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Surgery. FIGO stage IA-IB. \> 18 years

Exclusion criteria

* Ajuvant oncologic treatment

Design outcomes

Primary

Measure	Time frame
Prevalence of HPV Genotypes in Vagina (Type 16, 18 and Other)	2 years

Secondary

Measure	Time frame
HPV Clearance From Vagina in Between the Two Planned Follow-up Visits.	2 years

Other

Measure	Time frame
Evaluate 1-year, 2-year and 5-year Recurrence	5 years

Countries

Denmark

Contacts

Primary ContactKatrine Fuglsang, MD

katrine.fuglsang@ki.au.dk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026